South & Central America Bioproduction Market Forecast to 2030 - Regional Analysis - by Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), and End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others)
The South & Central America bioproduction market was valued at US$ 799.67 million in 2022 and is expected to reach US$ 1,965.21 million by 2030; it is estimated to register a CAGR of 11.9% from 2022 to 2030.
Patent Expiry of Blockbuster Biologics Fuels South & Central America Bioproduction Market
Biologicals represent promising new therapies for previously incurable diseases and are becoming highly important in the pharmaceuticals market. Patents on originator biologicals are expected to expire in the coming years.
Estimated patent and exclusivity expiry dates for best-selling biologicals are given in the following table.
Biologicals Expiry Dates
Avastin January 2022
Cyramza May 2023
Adcetris August 2023
Abthrax October 2024
Gazyva/Gazyvaro November 2024
Darzalex May 2026
Ocrevus April 2027
Emgality September 2028
Hemlibra February 2028
Llumetri March 2028
Imfinzi September 2028
Mylotarg April 2028
Imfinzi September 2028
Mylotarg April 2028
Sylvant July 2034
The patent expiration and other intellectual property rights for originator biologicals will create a need to introduce new biosimilars in the future. As a result, competition among market players will surge in the industry in the coming years. Thus, the patent expiry of blockbuster biologics is expected to create lucrative opportunities for the bioproduction market during the forecast period.
South & Central America Bioproduction Market Overview
The bioproduction market in South & Central America is subsegmented into Brazil, Argentina, and the Rest of South & Central America. Growing developments in the medical industry and increasing awareness regarding cell therapy in Brazil are likely to create significant growth opportunities for market growth. Similarly, the growing healthcare industry in Argentina is expected to offer growth opportunities for the bioproduction market.
According to an article published in Biomaterials Research, in 2020, Brazil was among the top ten countries in the world in terms of the highest number of people having diabetes, and it currently ranks fifth. Currently, Brazil is the fifth top country in the world with the highest prevalence of diabetes mellitus (DM) in adults. According to the International Diabetes Federation (IDF), it is estimated that an increase of 54.7% of new cases of diabetes by 2045.
According to GaBI, in 2022, the Brazilian Health Regulatory Agency (Ag?ncia Nacional de Vigilвncia Sanitбria, ANVISA) approved 30 biosimilars within the product classes of insulin, monoclonal antibodies, tumor necrosis factor (TNF) inhibitor, human growth hormone, anticoagulants and heparins, and granulocyte colony-stimulating factor for use in Brazil. The ANVISA approved Admelog biosimilar by Sanofi in Brazil to treat diabetes. Thus, growing diabetic cases and increasing product approvals in Brazil are driving the bioproduction market.
South & Central America Bioproduction Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Bioproduction Market Segmentation
The South & Central America bioproduction market is categorized into product, application, equipment, end user, and country.
Based on product, the South & Central America bioproduction market is segmented into biologics and biosimilars, vaccines, cell and gene therapies, nucleic acid therapeutics, and others. The biologics and biosimilars segment held the largest South & Central America bioproduction market share in 2022.
In terms of application, the South & Central America bioproduction market is segmented into rheumatoid arthritis, hematological disorders, cancer, diabetes, cardiovascular diseases, and others. The cancer segment held the largest South & Central America bioproduction market share in 2022.
By equipment, the South & Central America bioproduction market is divided into upstream equipment, downstream equipment, bioreactors, and consumables and accessories. The consumables and accessories segment held the largest South & Central America bioproduction market share in 2022.
In terms of end user, the South & Central America bioproduction market is categorized into biopharmaceutical companies, contract manufacturing organizations, and others. The biopharmaceutical companies segment held the largest South & Central America bioproduction market share in 2022.
By country, the South & Central America bioproduction market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America bioproduction market share in 2022.
Lonza Group AG, Danaher Corp, Sartorius AG, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd, and Bio-Rad Laboratories Inc. are some of the leading companies operating in the South & Central America bioproduction market.
Patent Expiry of Blockbuster Biologics Fuels South & Central America Bioproduction Market
Biologicals represent promising new therapies for previously incurable diseases and are becoming highly important in the pharmaceuticals market. Patents on originator biologicals are expected to expire in the coming years.
Estimated patent and exclusivity expiry dates for best-selling biologicals are given in the following table.
Biologicals Expiry Dates
Avastin January 2022
Cyramza May 2023
Adcetris August 2023
Abthrax October 2024
Gazyva/Gazyvaro November 2024
Darzalex May 2026
Ocrevus April 2027
Emgality September 2028
Hemlibra February 2028
Llumetri March 2028
Imfinzi September 2028
Mylotarg April 2028
Imfinzi September 2028
Mylotarg April 2028
Sylvant July 2034
The patent expiration and other intellectual property rights for originator biologicals will create a need to introduce new biosimilars in the future. As a result, competition among market players will surge in the industry in the coming years. Thus, the patent expiry of blockbuster biologics is expected to create lucrative opportunities for the bioproduction market during the forecast period.
South & Central America Bioproduction Market Overview
The bioproduction market in South & Central America is subsegmented into Brazil, Argentina, and the Rest of South & Central America. Growing developments in the medical industry and increasing awareness regarding cell therapy in Brazil are likely to create significant growth opportunities for market growth. Similarly, the growing healthcare industry in Argentina is expected to offer growth opportunities for the bioproduction market.
According to an article published in Biomaterials Research, in 2020, Brazil was among the top ten countries in the world in terms of the highest number of people having diabetes, and it currently ranks fifth. Currently, Brazil is the fifth top country in the world with the highest prevalence of diabetes mellitus (DM) in adults. According to the International Diabetes Federation (IDF), it is estimated that an increase of 54.7% of new cases of diabetes by 2045.
According to GaBI, in 2022, the Brazilian Health Regulatory Agency (Ag?ncia Nacional de Vigilвncia Sanitбria, ANVISA) approved 30 biosimilars within the product classes of insulin, monoclonal antibodies, tumor necrosis factor (TNF) inhibitor, human growth hormone, anticoagulants and heparins, and granulocyte colony-stimulating factor for use in Brazil. The ANVISA approved Admelog biosimilar by Sanofi in Brazil to treat diabetes. Thus, growing diabetic cases and increasing product approvals in Brazil are driving the bioproduction market.
South & Central America Bioproduction Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Bioproduction Market Segmentation
The South & Central America bioproduction market is categorized into product, application, equipment, end user, and country.
Based on product, the South & Central America bioproduction market is segmented into biologics and biosimilars, vaccines, cell and gene therapies, nucleic acid therapeutics, and others. The biologics and biosimilars segment held the largest South & Central America bioproduction market share in 2022.
In terms of application, the South & Central America bioproduction market is segmented into rheumatoid arthritis, hematological disorders, cancer, diabetes, cardiovascular diseases, and others. The cancer segment held the largest South & Central America bioproduction market share in 2022.
By equipment, the South & Central America bioproduction market is divided into upstream equipment, downstream equipment, bioreactors, and consumables and accessories. The consumables and accessories segment held the largest South & Central America bioproduction market share in 2022.
In terms of end user, the South & Central America bioproduction market is categorized into biopharmaceutical companies, contract manufacturing organizations, and others. The biopharmaceutical companies segment held the largest South & Central America bioproduction market share in 2022.
By country, the South & Central America bioproduction market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America bioproduction market share in 2022.
Lonza Group AG, Danaher Corp, Sartorius AG, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd, and Bio-Rad Laboratories Inc. are some of the leading companies operating in the South & Central America bioproduction market.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SOUTH & CENTRAL AMERICA BIOPRODUCTION MARKET - KEY INDUSTRY DYNAMICS
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. BIOPRODUCTION MARKET - SOUTH & CENTRAL AMERICA MARKET ANALYSIS
5.1 South & Central America Bioproduction Market Revenue (US$ Mn), 2020 - 2030
6. SOUTH & CENTRAL AMERICA BIOPRODUCTION MARKET - REVENUE AND FORECAST TO 2030 - BY PRODUCT
6.1 Overview
6.2 South & Central America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7. SOUTH & CENTRAL AMERICA BIOPRODUCTION MARKET - REVENUE AND FORECAST TO 2030 - BY APPLICATION
7.1 Overview
7.2 South & Central America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8. SOUTH & CENTRAL AMERICA BIOPRODUCTION MARKET - REVENUE AND FORECAST TO 2030 - BY EQUIPMENT
8.1 Overview
8.2 South & Central America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 South & Central America: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9. SOUTH & CENTRAL AMERICA BIOPRODUCTION MARKET - REVENUE AND FORECAST TO 2030 - BY END USER
9.1 Overview
9.2 South & Central America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10. SOUTH & CENTRAL AMERICA BIOPRODUCTION MARKET - REVENUE AND FORECAST TO 2030 - COUNTRY ANALYSIS
10.1 South & Central America: Bioproduction Market
10.1.1 South & Central America: Bioproduction Market Share by Country - 2022 & 2030, (%)
10.1.1.1 Brazil: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2 Brazil: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
10.1.1.2.1 Brazil: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.2 Brazil: Bioproduction Market, By Application, 2020-2030 (US$ Million)
10.1.1.2.3 Brazil: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)
10.1.1.2.3.1 Brazil: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.2.4 Brazil: Bioproduction Market, By End User, 2020-2030 (US$ Million)
10.1.1.3 Argentina: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.4 Argentina: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
10.1.1.4.1 Argentina: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.2 Argentina: Bioproduction Market, By Application, 2020-2030 (US$ Million)
10.1.1.4.3 Argentina: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)
10.1.1.4.3.1 Argentina: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.4.4 Argentina: Bioproduction Market, By End User, 2020-2030 (US$ Million)
10.1.1.5 Rest of South & Central America: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.6 Rest of South & Central America: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Rest of South & Central America: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.6.2 Rest of South & Central America: Bioproduction Market, By Application, 2020-2030 (US$ Million)
10.1.1.6.3 Rest of South & Central America: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)
10.1.1.6.3.1 Rest of South & Central America: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.6.4 Rest of South & Central America: Bioproduction Market, By End User, 2020-2030 (US$ Million)
11. BIOPRODUCTION MARKET-INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Danaher Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bio-Rad Laboratories Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. APPENDIX
13.1 About Us
13.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SOUTH & CENTRAL AMERICA BIOPRODUCTION MARKET - KEY INDUSTRY DYNAMICS
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. BIOPRODUCTION MARKET - SOUTH & CENTRAL AMERICA MARKET ANALYSIS
5.1 South & Central America Bioproduction Market Revenue (US$ Mn), 2020 - 2030
6. SOUTH & CENTRAL AMERICA BIOPRODUCTION MARKET - REVENUE AND FORECAST TO 2030 - BY PRODUCT
6.1 Overview
6.2 South & Central America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7. SOUTH & CENTRAL AMERICA BIOPRODUCTION MARKET - REVENUE AND FORECAST TO 2030 - BY APPLICATION
7.1 Overview
7.2 South & Central America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8. SOUTH & CENTRAL AMERICA BIOPRODUCTION MARKET - REVENUE AND FORECAST TO 2030 - BY EQUIPMENT
8.1 Overview
8.2 South & Central America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 South & Central America: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9. SOUTH & CENTRAL AMERICA BIOPRODUCTION MARKET - REVENUE AND FORECAST TO 2030 - BY END USER
9.1 Overview
9.2 South & Central America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10. SOUTH & CENTRAL AMERICA BIOPRODUCTION MARKET - REVENUE AND FORECAST TO 2030 - COUNTRY ANALYSIS
10.1 South & Central America: Bioproduction Market
10.1.1 South & Central America: Bioproduction Market Share by Country - 2022 & 2030, (%)
10.1.1.1 Brazil: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2 Brazil: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
10.1.1.2.1 Brazil: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.2 Brazil: Bioproduction Market, By Application, 2020-2030 (US$ Million)
10.1.1.2.3 Brazil: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)
10.1.1.2.3.1 Brazil: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.2.4 Brazil: Bioproduction Market, By End User, 2020-2030 (US$ Million)
10.1.1.3 Argentina: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.4 Argentina: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
10.1.1.4.1 Argentina: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.2 Argentina: Bioproduction Market, By Application, 2020-2030 (US$ Million)
10.1.1.4.3 Argentina: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)
10.1.1.4.3.1 Argentina: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.4.4 Argentina: Bioproduction Market, By End User, 2020-2030 (US$ Million)
10.1.1.5 Rest of South & Central America: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.6 Rest of South & Central America: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Rest of South & Central America: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.6.2 Rest of South & Central America: Bioproduction Market, By Application, 2020-2030 (US$ Million)
10.1.1.6.3 Rest of South & Central America: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)
10.1.1.6.3.1 Rest of South & Central America: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.6.4 Rest of South & Central America: Bioproduction Market, By End User, 2020-2030 (US$ Million)
11. BIOPRODUCTION MARKET-INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Danaher Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bio-Rad Laboratories Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. APPENDIX
13.1 About Us
13.2 Glossary of Terms
